Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
ATMARINOMED6
Thu, 17.08.2023       Marinomed Biotech AG
ATMARINOMED6

Marinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities Half-year results show revenue growth of 7% to € 5.2 million (H1 2022: € 4.9 million) Marinosolv: Business development activities for Tacrosolv and Budesolv in full force Carragelose: Successful market entry with nasal spray in M [ … ]
Technical analysis
To the publication
Wed, 09.08.2023       Marinomed Biotech AG
ATMARINOMED6

Marinomed enters first long-term Solv4U partnership with Shanghai-based SPH Sine Pharmaceutical Laboratories Co. Ltd. SPH Sine will use Marinomed's proprietary Marinosolv technology to dissolve its active pharmaceutical ingredient (API) in an orally inhaled and nasal drug product (OINDP) formulation The developed know-how technology of the unique [ … ]
Technical analysis
To the publication
Thu, 27.07.2023       Marinomed Biotech AG
ATMARINOMED6

Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico Marinomeds distribution partner M8 Pharmaceuticals obtained market approval for distribution and marketing of a Carragelose nasal spray in Mexico Launch of the product under the trade name Barlo® is planned for the upcoming season Promisi [ … ]
Technical analysis
To the publication
Thu, 27.07.2023       Marinomed Biotech AG
ATMARINOMED6

Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico Marinomeds distribution partner M8 Pharmaceuticals obtained market approval for distribution and marketing of a Carragelose nasal spray in Mexico Launch of the product under the trade name Barlo® is planned for the upcoming season Promisi [ … ]
Technical analysis
To the publication
Thu, 13.07.2023       Marinomed Biotech AG
ATMARINOMED6

Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan Joint publication of virologists in the peer-reviewed journal Nutraceuticals demonstrates effectiveness of iota-carrageenan (Carragelose) against SARS-CoV-2 Omicron variants BA.1,  [ … ]
Technical analysis
To the publication
Thu, 13.07.2023       Marinomed Biotech AG
ATMARINOMED6

Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan Joint publication of virologists in the peer-reviewed journal Nutraceuticals demonstrates effectiveness of iota-carrageenan (Carragelose) against SARS-CoV-2 Omicron variants BA.1,  [ … ]
Technical analysis
To the publication
Wed, 21.06.2023       Marinomed Biotech AG
ATMARINOMED6

Marinomed Biotech AG: Annual General Meeting elects Dr. Eva Hofstädter-Thalmann as a new member of the Supervisory Board Industry expert Dr. Eva Hofstädter-Thalmann complements high-profile Supervisory Board Dr. Simon Nebel and Mag. Brigitte Ederer reappointed Current female representation on Supervisory Board reaches at 60% Korneuburg, Austria [ … ]
Technical analysis
To the publication
Wed, 21.06.2023       Marinomed Biotech AG
ATMARINOMED6

Marinomed Biotech AG: Annual General Meeting elects Dr. Eva Hofstädter-Thalmann as a new member of the Supervisory Board Industry expert Dr. Eva Hofstädter-Thalmann complements high-profile Supervisory Board Dr. Simon Nebel and Mag. Brigitte Ederer reappointed Current female representation on Supervisory Board reaches at 60% Korneuburg, Austria [ … ]
Technical analysis
To the publication
Thu, 15.06.2023       Marinomed Biotech AG
ATMARINOMED6

 Marinomed Biotech AG prepares launch of Carragelose eye drops in 2024 Moisturizing eye drops complement existing Carragelose OTC product portfolio Benefits of Carragelose extended to application in the eye Single-territory test launch in Austria in preparation for 2024 and business development process for international roll-out initiated Korneu [ … ]
Technical analysis
To the publication
Thu, 15.06.2023       Marinomed Biotech AG
ATMARINOMED6

 Marinomed Biotech AG prepares launch of Carragelose eye drops in 2024 Moisturizing eye drops complement existing Carragelose OTC product portfolio Benefits of Carragelose extended to application in the eye Single-territory test launch in Austria in preparation for 2024 and business development process for international roll-out initiated Korneu [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Friday, 18.10.2024, Calendar Week 42, 292nd day of the year, 74 days remaining until EoY.